These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 16828406)

  • 1. Skin manifestations in acromegaly.
    Ben-Shlomo A; Melmed S
    Clin Dermatol; 2006; 24(4):256-9. PubMed ID: 16828406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermatologic manifestations of acromegaly: A case in point and a focused review.
    Degirmentepe EN; Gungor S; Kocaturk E; Kiziltac U; Adas M; Ozekinci S; Khachemoune A
    Dermatol Online J; 2017 Aug; 23(8):. PubMed ID: 29469738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
    Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease in growth hormone and insulin-like growth factor (IGF)-1 release and amelioration of acromegaly features after rosiglitazone treatment of type 2 diabetes mellitus a patient with acromegaly.
    Gradiser M; Matovinovic M; Vrkljan M
    Croat Med J; 2007 Feb; 48(1):87-91. PubMed ID: 17309144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
    Wiesli P; Zwimpfer C; Zapf J; Schmid C
    Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of measurements of insulin-like growth factor 1.
    Clemmons DR
    Nat Clin Pract Endocrinol Metab; 2006 Aug; 2(8):436-46. PubMed ID: 16932333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic growth hormone excess is associated with increased aldosterone: a study in patients with acromegaly and in growth hormone transgenic mice.
    Bielohuby M; Roemmler J; Manolopoulou J; Johnsen I; Sawitzky M; Schopohl J; Reincke M; Wolf E; Hoeflich A; Bidlingmaier M
    Exp Biol Med (Maywood); 2009 Aug; 234(8):1002-9. PubMed ID: 19491373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The GH-IGF-I axis and the cardiovascular system: clinical implications.
    Colao A
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):347-58. PubMed ID: 18462260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly.
    Colao A; Pivonello R; Cavallo LM; Gaccione M; Auriemma RS; Esposito F; Cappabianca P; Lombardi G
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):250-6. PubMed ID: 16886969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuated pulse size, disorderly growth hormone and prolactin secretion with preserved nyctohemeral rhythm distinguish irradiated from surgically treated acromegaly patients.
    van der Klaauw AA; Pereira AM; van Thiel SW; Frolich M; Iranmanesh A; Veldhuis JD; Roelfsema F; Romijn JA
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):489-98. PubMed ID: 17371464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and treatment of acromegaly.
    Katznelson L
    Growth Horm IGF Res; 2005 Jul; 15 Suppl A():S31-5. PubMed ID: 16023876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PPAR-gamma activator rosiglitazone fails to lower plasma growth hormone and insulin-like growth factor-1 levels in patients with acromegaly.
    Bastemir M; Akin F; Yaylali GF
    Neuroendocrinology; 2007; 86(2):119-23. PubMed ID: 17671378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-mediated pseudoacromegaly: a case report and review of the literature.
    Yaqub A; Yaqub N
    W V Med J; 2008; 104(5):12-5. PubMed ID: 18846753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cutaneous manifestations of acromegaly: 4 cases].
    Billon C; Beylot-Barry M; Doutre MS; Latapie JL; Roger P; Beylot C
    Ann Dermatol Venereol; 1996; 123(12):821-3. PubMed ID: 9636771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current diagnosis of acromegaly.
    Cordero RA; Barkan AL
    Rev Endocr Metab Disord; 2008 Mar; 9(1):13-9. PubMed ID: 18236162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feline acromegaly: a review of the syndrome.
    Hurty CA; Flatland B
    J Am Anim Hosp Assoc; 2005; 41(5):292-7. PubMed ID: 16141180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum ghrelin levels and disturbances of the lipid profile in patients with acromegaly.
    Jaskula M; Wasko R; Komarowska H; Dziubandowska A; Sowinski J
    Neuro Endocrinol Lett; 2009; 30(2):245-55. PubMed ID: 19675514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Secretion dynamics of GH in 43 patients with acromegaly].
    Liuzzi A; Chiodini PG; Botalla L; Cattabeni A; Tosi M; Cremascoli G
    Folia Endocrinol; 1972 Oct; 25(5):393-400. PubMed ID: 4679241
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum IGF-I measured by four different immunoassays in patients with adult GH deficiency or acromegaly and in a control population.
    Granada ML; Ulied A; Casanueva FF; Pico A; Lucas T; Torres E; Sanmartí A
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):942-50. PubMed ID: 17980002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical manifestations of acromegaly.
    Molitch ME
    Endocrinol Metab Clin North Am; 1992 Sep; 21(3):597-614. PubMed ID: 1521514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.